多发性骨髓瘤的向治疗:基于CD138的策略的概述
Federico Riccardi1, Carmela Tangredi1,2, Michele Dal Bo1
1Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
Frontiers in oncology
|April 24, 2024
概括
多发性骨髓瘤 (MM) 是一种无法治愈的癌症. 针对CD138的新疗法对治疗复发性/耐药性MM有希望,为改善患者的治疗结果提供希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 多发性骨髓瘤 (MM) 是一种无法治愈的血细胞癌.
- 目前的治疗方法对复发/耐药性疾病的成功有限.
- 针对CD38和SLAMF7的免疫疗法显示出有前途.
研究的目的:
- 为了提供多发性骨髓瘤的概述.
- 调查MM中CD138的分子功能.
- 审查MM中基于CD138的治疗策略.
主要方法:
- 关于MM疾病的文献综述.
- 对CD138分子功能的分析.
- 基于CD138的临床前和临床疗法的调查.
主要成果:
- 在恶性血细胞中,CD138的高调.
- CD138在MM的进展和攻击性中起着关键作用.
- 目前正在研究各种针对CD138的治疗方法.
结论:
- CD138是MM治疗的有前途的向抗原.
- 基于CD138的疗法代表了MM的新方法.
- 对CD138向剂的进一步研究是有必要的.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.7K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
